Olorophim by F2G and Shionogi & Co. is focused on invasive aspergillosis treatment.
fungal disease
Posted inInfections, New Drugs, Regulatory
Vivjoa: First Drug for Chronic Vaginal Yeast Infection
Oteseconazole by Mycovia Pharmaceuticals will prevent the risk of recurrent episodes of vulvovaginal candidiasis.
Posted inInfections, New Drugs, Regulatory
Brexafemme: New Drug for Vaginal Yeast Infection
Scynexis offered ibrexafungerp, a new antifungal medication for vulvovaginal candidiasis treatment.